Capital Fund Management S.A. Novo Nordisk A S Put Options Transaction History

Capital Fund Management S.A.

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 13, 2024	BUY	$119.07 - $145.42 $2.06 Million - $2.52 Million	17,300 Added 5.11%	355,800 $42.4 Million
Q2 2024 Aug 13, 2024	BUY	$122.71 - $146.91 $24.6 Million - $29.4 Million	200,400 Added 145.11%	338,500 $48.3 Million
Q1 2024 May 15, 2024	SELL	$102.11 - $135.92 $21.5 Million - $28.7 Million	-210,800 Reduced 60.42%	138,100 $17.7 Million
Q4 2023 Feb 14, 2024	BUY	$87.78 - $105.45 $26.1 Million - $31.3 Million	297,100 Added 573.55%	348,900 $36.1 Million
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $4.71 Million - $10.3 Million	51,800 New	51,800 $4.71 Million
Q4 2021 Feb 10, 2022	SELL	$95.88 - $117.08 $536,928 - $655,648	-5,600 Reduced 20.44%	21,800 $2.44 Million
Q3 2021 Nov 12, 2021	BUY	$84.42 - $106.62 $1.67 Million - $2.11 Million	19,800 Added 260.53%	27,400 $2.63 Million
Q1 2018 May 15, 2018	SELL	$48.49 - $58.14 $24,245 - $29,070	-500 Reduced 6.17%	7,600 $374,000
Q3 2017 Nov 13, 2017	BUY	$41.15 - $49.22 $333,315 - $398,682	8,100	8,100 $390,000

1,957

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $192B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.